Hepatology · 1995 · 29 citations · 29 references
PharmacyCell BiologyOncologyMolecular OncologyMonoclonal AntibodiesTumor ImmunologyAntibody CharacterizationAntibody ConjugatesHepatocellular CarcinomaTherapeutic Monoclonal AntibodiesTumor-associated AntigensCancer AntigensCell-surface Antigen TargetingCompetitive AssaysCompetitive Binding AssaysLiposomal Delivery SystemsLiposomesMonoclonal Antibodies In OncologyMonoclonal Antibody Interactions
The monoclonal antibody AF-20 was raised against the human hepatocellular carcinoma (HCC) cell line FOCUS and binds with high affinity to a rapidly internalized 180-kd homodimeric glycoprotein that is abundantly expressed on the surface of human HCC and other human cancer cell lines. Immunoliposomes were produced by covalently coupling AF-20 to liposomes containing carboxyfluorescein. Interaction of immunoliposomes with various HCC cell lines in vitro was quantitatively assessed by flow cytometry and qualitatively analyzed by fluorescence microscopy. Liposomes bearing an isotype-matched nonrelevant monoclonal antibody (MAb) and cell lines not expressing AF-20 antigen served as controls. AF-20-immunoliposomes specifically bound to HCC and other human cancer cell lines expressing the AF-20 antigen and were rapidly internalized at 37 degrees C. Interaction of AF-20-conjugated liposomes with these cell lines was between 5 and 200 times greater than that of unconjugated liposomes, whereas no difference was observed between control liposomes bearing a nonrelevant antibody and unconjugated liposomes. Specificity of liposome-target cell interaction was confirmed by competitive inhibition assays. Kinetic analysis showed rapid association of AF-20 immunoliposomes with target cells, with saturation conditions being reached after 60 minutes. We conclude that the MAb AF-20 directs highly efficient, specific, and rapid targeting of immunoliposomes to human HCC and other human cancer cell lines in vitro. This targeted liposomal delivery system represents a promising approach for the development of immunotargeted diagnosis and therapy strategies against HCC.
29
Antibodies, a laboratory manual
Biomedicine & Pharmacotherapy · 1989 · 12.5K citations
Antibodies: A laboratory manual
J.L. · Trends in Biochemical Sciences · 1989 · 5.2K citations
Current protocols in immunology
Roald Nezlin · Molecular Immunology · 1992 · 1.4K citations
Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.
Hidekazu Nakabayashi, Kazuhisa Taketa, Keiko Miyano et al. · PubMed · 1982 · 1.4K citations
Medicine, Cell Biology, Oncology +10